They are looking at the therapeutic window of the drug
And have decided on a recommended dose to proceed to the phase 2 of the program.
There is nothing more too it than this.
Ann: R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO, page-47
Add to My Watchlist
What is My Watchlist?